{"entity":{"type":"insider","cik":"0001402535","url":"/insider/0001402535","json_url":"/insider/0001402535.json","name":"Miller Steve","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":12,"first":"2012-07-05","last":"2025-08-28","span_basis":"filed_date"},"name_variants":[{"name":"Miller Steve","source":"filing","n_filings":12,"first_seen":"2012-07-05","last_seen":"2025-08-28"}],"transactions":[{"id":4671763,"accession":"0001161697-25-000301","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-25-000301","line_url":"/filing/0001161697-25-000301#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Op. & Scientific Officer)","officer_title":"Chief Op. & Scientific Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115000.0,"shares_display":"115,000","price_per_share":20.28,"price_display":"20.28","price_state":"stated","total_value":2332200.0,"total_display":"2,332,200.00","shares_owned_after":949663.0,"shares_owned_after_display":"949,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-28","scope":"insider"},{"id":2886916,"accession":"0001161697-24-000505","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001161697-24-000505","line_url":"/filing/0001161697-24-000505#line-3","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Op. & Scientific Officer)","officer_title":"Chief Op. & Scientific Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":21.927,"price_display":"21.93","price_state":"stated","total_value":1096350.0,"total_display":"1,096,350.00","shares_owned_after":686996.0,"shares_owned_after_display":"686,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-11","scope":"insider"},{"id":2178102,"accession":"0001161697-24-000367","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001161697-24-000367","line_url":"/filing/0001161697-24-000367#line-3","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Op. & Scientific Officer)","officer_title":"Chief Op. & Scientific Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":20.585,"price_display":"20.58","price_state":"stated","total_value":1029250.0,"total_display":"1,029,250.00","shares_owned_after":675124.0,"shares_owned_after_display":"675,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-22","scope":"insider"},{"id":2178099,"accession":"0001161697-24-000367","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-24-000367","line_url":"/filing/0001161697-24-000367#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Op. & Scientific Officer)","officer_title":"Chief Op. & Scientific Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":20.261,"price_display":"20.26","price_state":"stated","total_value":1013050.0,"total_display":"1,013,050.00","shares_owned_after":775124.0,"shares_owned_after_display":"775,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-22","scope":"insider"},{"id":2178097,"accession":"0001161697-24-000367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-24-000367","line_url":"/filing/0001161697-24-000367#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Op. & Scientific Officer)","officer_title":"Chief Op. & Scientific Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":20.212,"price_display":"20.21","price_state":"stated","total_value":1010600.0,"total_display":"1,010,600.00","shares_owned_after":725124.0,"shares_owned_after_display":"725,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-22","scope":"insider"},{"id":8182336,"accession":"0001161697-23-000586","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-23-000586","line_url":"/filing/0001161697-23-000586#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Op. & Scientific Officer)","officer_title":"Chief Op. & Scientific Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":14.24,"price_display":"14.24","price_state":"stated","total_value":569600.0,"total_display":"569,600.00","shares_owned_after":647457.0,"shares_owned_after_display":"647,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-07","scope":"insider"},{"id":6445416,"accession":"0001161697-22-000561","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-22-000561","line_url":"/filing/0001161697-22-000561#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":17.337,"price_display":"17.34","price_state":"stated","total_value":346740.0,"total_display":"346,740.00","shares_owned_after":553791.0,"shares_owned_after_display":"553,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-23","filed_date":"2022-11-23","scope":"insider"},{"id":6445412,"accession":"0001161697-22-000561","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000561","line_url":"/filing/0001161697-22-000561#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":15.276,"price_display":"15.28","price_state":"stated","total_value":1222080.0,"total_display":"1,222,080.00","shares_owned_after":573791.0,"shares_owned_after_display":"573,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-23","scope":"insider"},{"id":6271179,"accession":"0001161697-22-000456","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001161697-22-000456","line_url":"/filing/0001161697-22-000456#line-3","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":16.846,"price_display":"16.85","price_state":"stated","total_value":1263450.0,"total_display":"1,263,450.00","shares_owned_after":653791.0,"shares_owned_after_display":"653,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-13","filed_date":"2022-09-15","scope":"insider"},{"id":6271177,"accession":"0001161697-22-000456","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-22-000456","line_url":"/filing/0001161697-22-000456#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":17.007,"price_display":"17.01","price_state":"stated","total_value":425175.0,"total_display":"425,175.00","shares_owned_after":736724.0,"shares_owned_after_display":"736,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-13","filed_date":"2022-09-15","scope":"insider"},{"id":6271175,"accession":"0001161697-22-000456","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000456","line_url":"/filing/0001161697-22-000456#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7933.0,"shares_display":"7,933","price_per_share":17.111,"price_display":"17.11","price_state":"stated","total_value":135741.563,"total_display":"135,741.56","shares_owned_after":728791.0,"shares_owned_after_display":"728,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-13","filed_date":"2022-09-15","scope":"insider"},{"id":6692233,"accession":"0001161697-22-000400","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-22-000400","line_url":"/filing/0001161697-22-000400#line-4","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":118575.0,"shares_display":"118,575","price_per_share":13.559,"price_display":"13.56","price_state":"stated","total_value":1607758.425,"total_display":"1,607,758.42","shares_owned_after":761724.0,"shares_owned_after_display":"761,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-18","filed_date":"2022-08-19","scope":"insider"},{"id":6692225,"accession":"0001161697-22-000400","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000400","line_url":"/filing/0001161697-22-000400#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31425.0,"shares_display":"31,425","price_per_share":13.434,"price_display":"13.43","price_state":"stated","total_value":422163.45,"total_display":"422,163.45","shares_owned_after":761724.0,"shares_owned_after_display":"761,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-18","filed_date":"2022-08-19","scope":"insider"},{"id":4686801,"accession":"0001161697-21-000410","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-21-000410","line_url":"/filing/0001161697-21-000410#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":5.558,"price_display":"5.56","price_state":"stated","total_value":444640.0,"total_display":"444,640.00","shares_owned_after":741724.0,"shares_owned_after_display":"741,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-25","filed_date":"2021-08-26","scope":"insider"},{"id":4135148,"accession":"0001161697-21-000385","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-21-000385","line_url":"/filing/0001161697-21-000385#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40963.0,"shares_display":"40,963","price_per_share":6.0888,"price_display":"6.09","price_state":"stated","total_value":249415.5144,"total_display":"249,415.51","shares_owned_after":701724.0,"shares_owned_after_display":"701,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-13","filed_date":"2021-08-17","scope":"insider"},{"id":2272031,"accession":"0001161697-16-000618","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-16-000618","line_url":"/filing/0001161697-16-000618#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7933.0,"shares_display":"7,933","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":14279.4,"total_display":"14,279.40","shares_owned_after":457687.0,"shares_owned_after_display":"457,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-11","filed_date":"2016-01-12","scope":"insider"},{"id":6405194,"accession":"0001161697-14-000235","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-14-000235","line_url":"/filing/0001161697-14-000235#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":2.1699,"price_display":"2.17","price_state":"stated","total_value":216990.0,"total_display":"216,990.00","shares_owned_after":214754.0,"shares_owned_after_display":"214,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-04","filed_date":"2014-06-04","scope":"insider"},{"id":3076340,"accession":"0001161697-12-000527","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-12-000527","line_url":"/filing/0001161697-12-000527#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27700.0,"shares_display":"27,700","price_per_share":0.55,"price_display":"0.55","price_state":"stated","total_value":15235.0,"total_display":"15,235.00","shares_owned_after":114754.0,"shares_owned_after_display":"114,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-03","filed_date":"2012-07-05","scope":"insider"},{"id":3076328,"accession":"0001161697-12-000527","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-12-000527","line_url":"/filing/0001161697-12-000527#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402535","owner_name":"Miller Steve","owner_url":"/insider/0001402535","role":"Officer (Chief Operating Officer)","officer_title":"Chief Operating Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12300.0,"shares_display":"12,300","price_per_share":0.546,"price_display":"0.55","price_state":"stated","total_value":6715.8,"total_display":"6,715.80","shares_owned_after":87054.0,"shares_owned_after_display":"87,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-03","filed_date":"2012-07-05","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001369568","name":"CATALYST PHARMACEUTICALS, INC.","url":"/issuer/0001369568","role":"Officer (Chief Op. & Scientific Officer)","n_filings":12,"first_seen":"2012-07-05","last_seen":"2025-08-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001402535","retrieved_at":"2026-08-21T01:59:22+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}